Commonwealth Numbered Regulations

1988 No. 42 FAMILY LAW REGULATIONS (AMENDMENT) - REG 4

4. Schedule 1 to the Family Law Regulations is amended by adding at the end
the following forms:

"FORM 2
Subregulation 21D (3)
PARENTAGE TESTING PROCEDURE:
COLLECTION OF BLOOD SAMPLES NAME OF CHILD WHOSE PARENTAGE IS IN ISSUE:
I, (name of sampler)                                   , of (address),

(occupation)                        collected blood from the following

person/*s at                 *am/*pm on (give date) at
(identify place of collection):
   (name of person)                                        photograph

  *(name of person)                                        photograph

  *(name of person)                                        photograph

  *(name of person)                                        photograph

2. When collecting the blood from *that person/*those persons, I strictly
observed the procedures provided under Part IIA of the Family Law Regulations
and placed *the blood sample/*each of the blood samples in a container bearing
the name of the person from whom it was collected, the time at which and date
on which it was collected and my signature.
Dated                          19  .
(Signature) *Omit if not applicable.

"FORM 3
Subregulation 21D (3)
Regulation 21E
PARENTAGE TESTING PROCEDURE
AFFIDAVIT BY/IN RELATION TO PERSON UNDERGOING PROCEDURE NAME OF CHILD WHOSE
PARENTAGE IS IN ISSUE:
I, (name)                           , of (address)                    ,
(occupation)

*make oath and say/*affirm:
1PART I
2. My racial background is
3. In the last 2 years: I *have/*have not suffered from leukaemia. I
*have/*have not suffered from haemolytic anaemia. I *have/*have not suffered
from chronic granulomatous disease.

*4. The particulars of the *leukaemia/*haemolytic anaemia/*chronic
granulomatous disease are as follows:
(give particulars)
5. I *have/*have not received a transfusion of blood or a blood product within
the last 4 months.

*6. The particulars of the transfusion of blood or blood product are as
follows:
(give particulars)
7. I *have/*have not taken any medication within the last month.

*8. The particulars of the medication are as follows:
(give particulars)
2PART II
2. I am the (state relationship or other status in relation to the person
undergoing procedure) of (name of person undergoing procedure) who was born on
(date of birth of person undergoing procedure).
3. (Name of person undergoing procedure) is a person whose racial background
is
4. In the last 2 years: *he/*she *has/*has not suffered from leukaemia.

*he/*she *has/*has not suffered from haemolytic anaemia. *he/*she *has/*has
not suffered from chronic granulomatous disease.

*5. The particulars of the *leukaemia/*haemolytic anaemia/*chronic
granulomatous disease are as follows:
(give particulars)
6. *He/*she *has/*has not received a transfusion of blood or a blood product
within the last 4 months.

*7. The particulars of the transfusion of blood or blood product are as
follows:
(give particulars)
8. (Name of person undergoing procedure) *has/*has not taken any medication
during the past month.

*9. The particulars of the medication are as follows:
(give particulars)

*SWORN/*AFFIRMED by the deponent at
on             19 .

(Signature of deponent) Before me: (Signature of person before whom the
affidavit is sworn or affirmed)

*Omit if not applicable 1 Part I is to be completed where the deponent is the
person from whom the blood sample is taken. 2 Part II is to be completed where
the deponent is a person other than the person from whom the blood sample is
taken.

"FORM 4
Regulation 21G
REPORT IN RELATION TO PARENTAGE TESTING NAME OF CHILD WHOSE PARENTAGE IS IN
ISSUE:
PART I
I,             (name of person making report), of        (address)

, (occupation)      , being *a person appointed by the Attorney-General/*a
person within a class of persons employed at a particular place appointed by
the Attorney-General to prepare reports of the kind referred to in paragraph
66W (9) (b) of the Family Law Act 1975, report that *a parentage testing
procedure/*parentage testing procedures being *red cell antigen blood
grouping/*red cell enzyme blood grouping/*serum markers/*HLA tissue
typing/*DNA typing of restriction fragment length polymorphisms *has/*have
been carried out on samples of blood in sealed containers bearing the names of
the following persons:
(name of person)
(name of person)
(name of person)
(name of person)
2. The samples of blood are the same samples as those referred to in the
form/*s in accordance with Form 2 in Schedule 1 to the Family Law Regulations
completed by (name of sampler) on                   19 .

3. The parentage testing *procedure was/*procedures were carried out at
(specify laboratory or laboratories).
4. The results of the parentage testing procedure/*s are set out in Part II of
this report.

*5. I report that the results of the parentage testing procedure/*s carried
out on the sample of blood in the container bearing the name of (name of
putative parent) show that (name of putative parent) is not excluded from
identification as the *father/*mother of the person from whom the blood in the
container bearing the name of (name of child whose parentage is in issue) was
taken. I further report:
(Set out explanation of the likelihood that putative parent is the biological
parent of the child)
or

*5. I report that the results of the parentage testing procedure/*s carried
out on the sample of blood in the container bearing the name of (name of
putative parent) show that (name of putative parent) is excluded from
identification as the *father/*mother of the person from whom the blood in the
container bearing the name of (name of child whose parentage is in issue) was
taken. I further report that the exclusion is based on contradictions to the
laws of genetic inheritance in (number) of the (number) genetic markers
tested. The contradictions occurred in the following genetic markers:
(Set out names of genetic markers and whether the contradictions were of the
first or second order)
Dated                    19    .

(Signature of person making
the report)

*Omit if not applicable.
PART II
1. The samples of blood referred to in Part I were received at (place at which
the parentage testing *procedure was/*procedures were carried out) on 19 .
2. The following identification numbers were allocated respectively to the
samples of blood in the containers in which the *procedure was/*procedures
were carried out:
(name of person)                                (identification number)

(name of person)                                (identification number)

(name of person)                                (identification number)

(name of person)                                (identification number)

3. (Set out here results obtained from the parentage testing procedure/*s).
1*4.The above results refer to the parentage testing procedure/*s carried out
on 19 , the samples being tested against the same reagents and in parallel
with appropriate known controls from a proven blood cell panel. Results from
controls show that all reagents were of correct specificity and normal
potency. I am satisfied that the results obtained are true and that they have
been correctly transcribed from the laboratory workbooks.
or 2*4.The above results refer to the parentage testing procedure carried out
under my supervision on 19 , the samples being tested against the same probes
and in parallel with appropriate known controls from a proven blood cell
panel. Fragment length patterns were in accordance with scientifically
accepted standards. I am satisfied that the results obtained have been
correctly coded from the fragment pattern and that they have been correctly
transcribed from the laboratory workbooks. Dated 19 .
(Signature of person
carrying out the parentage
testing procedure/*s)

*Omit if not applicable. 1 To be included where one or more of the following
parentage testing procedures is carried out: red cell antigen blood grouping,
red cell enzyme blood grouping, HLA tissue typing or serum markers. 2 To be
included where the parentage testing procedure carried out is DNA typing of
restriction fragment length polymorphisms.".